Several studies during the last years have shown that, in addition to endothelial cells, vascular smooth muscle cells also express the cellular adhesion molecules ICAM-1 and VCAM-1 in atherosclerosis, restenosis and transplant vasculopathy. In vitro studies have characterized stimulatory and inhibitory factors that regulate the expression of ICAM-1 and VCAM-1 on cultured smooth muscle cells. There is evidence for a role of adhesion molecules on smooth muscle cells for leukocyte accumulation and activation of mononuclear cells. Some recent data suggest that the expression of adhesion molecules on smooth muscle cells are cell cycle-dependent and influence smooth muscle cell proliferation and differentiation. Therefore, ICAM-1 and VCAM-1 on smooth muscle cells may contribute to the inflammatory reaction in the vascular wall and may actively be involved in the progression and stability of atherosclerotic plaques.
Introduction
Some years ago, the expression of ICAM-1 and VCAM-1 was also detected on intimal smooth muscle cells in the It is well established that interactions of endothelial cells atherosclerotic vascular wall [2] . This was a surprising and leukocytes via cell adhesion molecules play an imfinding that raised the question of the biological relevance portant role for leukocyte recruitment in atherogenesis of these molecules. [1, 2] . Besides selectins, the adhesion molecules of the This review gives an overview of the data available on immunoglobulin family intercellular adhesion molecule-1 the regulation and biological functions of ICAM-1 and (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-VCAM-1 on smooth muscle cells and its possible implica-1) contribute to the adhesion of leukocytes to activated tions in vascular diseases. endothelium [3] . ICAM-1 binds to LFA-1 (CD18 / CD11a) or Mac-1 (CD18 / CD11b) and mediates the adhesion of monocytes, lymphocytes and neutrophils to endothelial 2. Expression of cellular adhesion molecules on cells. In addition to its role in cell-cell adhesion, ICAM-1 smooth muscle cells in human vascular diseases also serves as a receptor for soluble fibrinogen and hyaluronic acid [4] . VCAM-1 binds to VLA (integrin 2.1. Atherosclerosis 4 a4/b1) on lymphocytes and monocytes [5] . Elevated levels of soluble adhesion molecules have been measured Evidence for the expression of adhesion molecules on in patients with atherosclerosis [6] . High levels of soluble smooth muscle cells in human aortae and coronary arteries ICAM-1 were observed in variant angina [6] and correcame from immunohistochemical studies using antibodies lated with the risk of future myocardial infarction [7] . against ICAM-1 or VCAM-1 and cell-specific antigens. Whereas ICAM-1 expression could not be detected on smooth muscle cells in the normal adult aorta, expression 2.2. Transplant vasculopathy of this adhesion molecule was observed on smooth muscle cells in the intima of atherosclerotic lesions [8, 9] . In There are only a few investigations of adhesion moleaddition, ICAM-1 expression was occasionally seen in cule expression in allograft vasculopathy. Biopsies of some medial smooth muscle cells adjacent to atherosrejected kidney allografts demonstrated an upregulation of clerotic plaques [10] . Similarly, VCAM-1 expression was endothelial cell adhesion molecules and a marked de novo detected on intimal smooth muscle cells in atherosclerotic expression of VCAM-1 on intimal as well as medial coronary arteries [11] as well as in aortae and carotid smooth muscle cells [19, 20] . In a murine model of cardiac arteries [12] . Several investigations demonstrated a correallograft vasculopathy endothelial expression of ICAM-1 lation between ICAM-1 [11] and VCAM-1 expression and VCAM-1 was also observed in control hearts whereas [11] [12] [13] on smooth muscle cells and mononuclear cell the expression of VCAM-1 on intimal and medial smooth infiltration suggesting that mediators derived from these muscle cells was unique for the cardiac allograft [21] . The mononuclear cells may contribute to the induction of positive correlation of VCAM-1 expression and mononuadhesion molecules in smooth muscle cells in vivo. On the clear cell infiltration in kidney allografts suggests direct other hand, the expression of adhesion molecules on interactions of smooth muscle cells and leukocytes which smooth muscle cells may facilitate the accumulation of might contribute to the progression of the disease [20] . transmigrated leukocytes within the vascular wall [14] . ICAM-1 and VCAM-1 expression on smooth muscle cells 2.3. Restenosis in the intima and media was most prominent in fibrous plaques and advanced atherosclerotic lesions [15] . In Data on the expression of adhesion molecules on smooth atherosclerotic coronary arteries, the expression of VCAMmuscle cells in restenosis came exclusively from animal 1 was prevalent in smooth muscle cells and macrophages studies. In the rabbit aorta, induction of ICAM-1 expresin the base of the plaques and in intimal neovasculature sion on endothelial cells was observed 2 days after balloon [11] [12] [13] . There was a strong association of the intensity of injury. In neointimal smooth muscle cells, however, a immunostaining of intimal neovessels for VCAM-1 and the marked expression of ICAM-1 was detected after 5 to 10 mononuclear cell infiltration, suggesting a role of the days and remained constant for at least 30 days after the neovasculature in leukocyte recruitment to the vascular injury [22] . In contrast to the strong endothelial expression wall [13] .
of VCAM-1 in this model, neointimal smooth muscle cells There are discrepant findings on the onset of adhesion demonstrated only a weak immunostaining [23] . molecule expression in smooth muscle cells in different Balloon injury of rat carotid arteries resulted in a strong experimental models of atherosclerosis. In hypercholesexpression of ICAM-1 on medial smooth muscle cells after terolemia-induced atheromatosis in rabbits, VCAM-1 ex-1 and 2 days [24] . The expression of ICAM-1 on neointipression on endothelial cells was a very early observation mal smooth muscle cells and regenerating endothelial cells whereas VCAM-1 expression on intimal smooth muscle was observed later, 5 to 7 days after the injury. At this cells and occasionally on medial smooth muscle cells time-point, medial ICAM-1 expression was decreased [24] . adjacent to atheromae occurred later in the development of Treatment of the animals with an antibody against ICAM-1 the disease [16] . In contrast, in ApoE-and LDL-receptorfor 6 days resulted in a significant reduction of neointima deficient mice, a striking VCAM-1 expression in the media formation in this model [24] . Interestingly, no reduction of in areas prone to lesion development was observed, mononuclear cell infiltration was observed. Consistent with whereas endothelial immunostaining was diffuse [17] . The this observation was the lack of effect of an antibody expression of VCAM-1 on medial smooth muscle cells against LFA-1, suggesting LFA-1-independent functions of occurred prior to or coincident with mononuclear cell ICAM-1 in the development of neointima proliferation in infiltration. In atherosclerotic vessels, VCAM-1 expression this model [24] . The time-course of treatment suggests was detected in medial smooth muscle cells at the base of ICAM-1 expression on medial smooth muscle cells as the the lesions as well as in the fibrous cap [17] .
primary target of the beneficial effects obtained by the Recently, a strong focal expression of ICAM-1 in antibody treatment [25] . smooth muscle cells and endothelial cells in the outer wall of the internal carotid artery in man was observed preceding mononuclear cell infiltration [18] . This vascular region 3. Regulation of adhesion molecule expression on has a high risk for atherosclerotic lesion development smooth muscle cells because of hemodynamic characteristics such as low shear stress and oscillations of flow [18] . These findings suggest, 3. [2, 11] . The mononuclear cell infiltration in the Table 1 demonstrates some discrepant effects of some atherosclerotic vessel wall mainly consists of macrophages of these cytokines on human vascular smooth muscle cells and T lymphocytes [1, 26, 27] . In atherosclerotic plaques, T in the different studies. Different cell isolation and cultivalymphocytes are often located in the fibrous cap together tion procedures, different number of cell passages, differwith smooth muscle cells [28] . A substantial amount of the ent experimental protocols as well as detection methods T cells is activated as indicated by HLA-DR and VLA may account for these discrepancies. In addition, there is 1 expression [29] . Activated T lymphocytes and macroevidence from our laboratory for differences in the rephages generate and release several cytokines with a sponse of smooth muscle cells of different vascular origin. number of biological effects on neighbouring cells [1] .
IL-4 had no effect on ICAM-1 expression in smooth Significant amounts of TNFa and IL-1b, mainly secreted muscle cells from human coronary arteries as well as by macrophages, as well as interferon (IFN)-g, an imsaphenous veins [38] . In contrast, Il-4 induced the expresportant T cell derived cytokine, have been detected in the sion of VCAM-1 on cells from saphenous vein whereas it atherosclerotic vessel wall [29] [30] [31] [32] . had no effect on coronary smooth muscle cells [42] . Several in vitro studies have investigated the effects of cytokines on the expression of ICAM-1 and VCAM-1 on 3.2. Role of growth factors cultured human smooth muscle cells. The table demonstrates the effects of cytokines on adhesion molecule Few studies deal with the effects of growth factors on expression on human smooth muscle cells isolated from adhesion molecule expression on smooth muscle cells. In different vascular regions [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . The induction of cells isolated from shunt arteries, PDGF-BB and -AB but adhesion molecules by cytokines is based on de novo not -AA induced the expression of ICAM-1. This stimula- [39] . In endothelial mediators may be physiologically important. contrast, TGFb had no significant effect on VCAM-1
Under pathophysiological conditions, such as atheroscleroexpression in umbilical vein endothelial cells [43] .
sis, endothelial cells change their repertoire of functional activities which might contribute to the expression of adhesion molecules on smooth muscle cells. In addition to 3.3. Role of low density lipoproteins other well characterized effects, the inhibition of adhesion molecule expression on smooth muscle cells may contribOxidized and minimally modified low density lipoproute to the established beneficial effects of the NO precursor teins (LDLs) increased the adhesion of monocytes to L-arginine [49] as well as the prostacyclin mimetic cicaphuman coronary smooth muscle cells, whereas native rost in experimental atherosclerosis models [50] . LDLs had no effect [41] . However, an upregulation of adhesion molecules was not induced on smooth muscle cells by modified LDLs. Therefore, the observed monocyte adhesion involves pathways different from ICAM-1 and 4. Biological functions of adhesion molecules on VCAM-1 and their respective ligands [41] . In contrast to smooth muscle cells these findings, both, native and oxidized LDLs, elicited adhesion molecule expression on endothelial cells [44] [45] [46] .
Interactions of leukocytes and smooth muscle cells
The adhesion of monocytes and lymphocytes to cyto-3. 4 
. Inhibitors of adhesion molecule expression in
kine-stimulated smooth muscle cells could be antagonized smooth muscle cells by neutralizing antibodies against ICAM-1 or VCAM-1 in adhesion assays in vitro [33, 34, 39, 41] . Recently it has been demonstrated that co-cultivation of
The biological consequences of adhesion of leukocytes smooth muscle cells and endothelial cells inhibits basal to smooth muscle cells are not well characterized. In vitro, and TNFa-induced expression of VCAM-1 on smooth the production of macrophage inflammatory protein 1 muscle cells [39] . A similar effect was achieved by (MIP-1) was activated in monocytes cultured on ICAM-1-exogenously added TGFb. Thus, endothelium-derived coated plates [51] . Recently, an increase in procoagulant TGFb has been suggested to be the responsible endothelial activity of monocytes by adhesion to smooth muscle cells mediator. However, the effect of endothelial cells could has been described. This effect was associated with an not be prevented by an antibody against TGFb [39] .
increase in tissue factor mRNA and protein synthesis by Besides TGFb, the roles of two other endotheliummonocytes and was specifically blocked by an antibody derived mediators, nitric oxide (NO) and prostacyclin were against ICAM-1 [52] . not investigated in this study. Recently, the NO donors ICAM-1 and VCAM-1 can act as co-stimulatory signals SIN-1 and sodium nitroprusside have been shown to in T cell stimulation during antigen presentation [53] . inhibit IL-1-induced expression of ICAM-1 and IFNgSeveral studies have demonstrated that smooth muscle induced expression of VCAM-1 on smooth muscle cells cells in the atherosclerotic vessel wall can express MHC II isolated from human aorta and saphenous vein [47] . This proteins and, therefore, a role of these cells in antigen effect of NO was independent of stimulation of the soluble presentation to T lymphocytes has been postulated guanylate cyclase [47] . The effect of NO donors occurred [26, 28, 54] . Detailed experimental studies, however, reat the transcriptional level and involved inhibition of both vealed that MHC II positive smooth muscle cells effectivebasal and IL-1-stimulated NFkB activity [47] .
ly stimulate pre-activated alloreactive T cells but failed to We have recently shown that the prostacyclin mimetic stimulate resting T cells suggesting a lack of important cicaprost significantly inhibits TNFa-and Il-1b-induced co-stimulators [55, 56] . expression of VCAM-1 and to a lesser extent of ICAM-1 Recently, it has been shown that induction of adhesion on smooth muscle cells from human coronary arteries and molecules on endothelial cells by activated leukocytes can saphenous veins. This inhibition occurred at the transcripbe observed independently of cytokines by an interaction tional level and was mediated by an increase in cAMP between CD40Ligand on leukocytes and CD40 on endolevels [48] . In contrast, there was no effect of cicaprost and thelial cells [57] . Similarly, a recent observation demonother cAMP elevating substances on IFNg-induced expresstrated that the expression of ICAM-1 and VCAM-1 on sion of ICAM-1. Therefore, the observed effects of cAMP smooth muscle cells can be induced by CD40-involve inhibition of certain signaling pathways that are CD40Ligand interactions [Regitz-Zagrosek, personal comshared by TNFa and Il-1b but not by IFNg [48] . munication].
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http://cardiovascres.oxfordjournals.org/ Downloaded from 4.2. Differentiation of smooth muscle cells aluronic acid on cell adhesion and migration [65] . There is evidence for an important role of hyaluronic acid for ICAM-1 [58] and VCAM-1 [59] are expressed on smooth muscle cell migration in restenosis [66, 67] . Reimmature fetal smooth muscle cells during embryogenesis.
cently, a marked upregulation of ICAM-1 and hyaluronic In embryonic mice, a strong expression of VCAM-1 was acid expression in smooth muscle cells after mechanical observed especially in the mesenchyme which is assumed injury in vitro has been reported. An antibody against to be the source of developing smooth muscle cells [60] .
ICAM-1 significantly reduced injury-induced smooth musKnockout mice for VCAM-1 or its ligand VLA showed cle cell DNA synthesis [68] . Therefore, the inhibition of 4 alterations in the development of the heart and circulation ICAM-1-hyaluronic acid interactions may contribute to such as failure of the formation of epicardium and the the beneficial effects of antibodies against ICAM-1 in coronary vasculature and poorly developed myocardium experimental restenosis models [24, 68] . [61, 62] . ICAM-1 and VCAM-1 expression decreases during ontogeny and both adhesion molecules are absent on differentiated contractile smooth muscle cells in the media of adult arteries [58, 59] . In atherosclerosis, transplant 5. Summary and conclusions vasculopathy and restenosis smooth muscle cells undergo a phenotypic change from the contractile to a ''synthetic'' Cellular adhesion molecules are expressed on smooth cell type resembling fetal smooth muscle cells [2, 21, 63] . smooth muscle cells in adhering monocytes and lymphocytes. Therefore, they may contribute to leukocyte acRecently, it has been shown that the expression of cumulation within the vascular wall and thereby influence VCAM-1, induced by the cytokine TNFa, is cell cyclethe cellular composition of atherosclerotic plaques. There dependent [64] . The induction of VCAM-1 is much are first reports demonstrating a role of ICAM-1 in the weaker in proliferating cells compared to quiescent cells.
activation of mononuclear cells. Cell cycle arrest in the S phase of proliferating cells Smooth muscle cell migration and proliferation and resulted in a significant inhibition of VCAM-1 expression extracellular matrix production are relevant for the stability [64] .
of atherosclerotic plaques whereas the accumulation of In addition to b integrins, there are different ligands for macrophages and T cells and their production of proteases 2 ICAM-1, i.e. fibrinogen, which has been suggested to and certain cytokines are correlated with plaque instability mediate cell proliferation via this adhesion molecule [25] . [69] . Therefore, taking into account all data presented here, ICAM-1 also has at least two binding domains for hyadhesion molecules on smooth muscle cells may not only aluronic acid [65] . Hyaluronic acid and its binding proteins be important in plaque progression but also influence have been implicated in cell growth, migration and difplaque stability. ferentiation [65] . The specific role of ICAM-1-hyaluronic In summary, data on the regulation of adhesion moleacid interactions have not been clearly defined. However, cules on vascular smooth muscle cells in vitro and in vivo the association of ICAM-1 with the cytoskeleton suggests are accumulating. However, further studies are still necesthat this adhesion molecule may mediate effects of hysary to complete our knowledge of their role in the 
